No abstract available
Keywords:
BCR, B-cell receptor; CML, chronic myeloid leukemia; DRESS, drug rash with eosinophilia and systemic symptoms; HES, hypereosinophilic syndrome.
PubMed Disclaimer
Conflict of interest statement
References
-
-
Klion A.D. How I treat hypereosinophilic syndromes. Blood. 2015;126(9):1069–1077.
-
PMC
-
PubMed
-
-
Kazmierowski J.A., Chusid M.J., Parrillo J.E., Fauci A.S., Wolff S.M. Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol. 1978;114(4):531–535.
-
PubMed
-
-
Reiter A., Gotlib J. Myeloid neoplasms with eosinophilia. Blood. 2017;129(6):704–714.
-
PubMed
-
-
Havelange V., Demoulin J.B. Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia. J Blood Med. 2013;4:111–121.
-
PMC
-
PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources